Cell & Gene Therapy Innovation Speaker

BryanDeane.jpeg

Troels Jordansen

CEO

With 30 years healthcare experience of which 20 years with cellular therapy Troels has a unique background for leading Glycostem through to the approval of one of the first (if not the first) off-the-shelf cellular immunotherapy products. Troels has been part of management teams launching 3 cellular therapies across the world and raising in excess of €160 million.